Agios Pharma (AGIO)

Agios Pharma (AGIO) Stock Price & Analysis


AGIO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$21.07 - $31.87
Previous Close$24.75
Average Volume (3M)341.63K
Market Cap
Enterprise Value$755.93M
Total Cash (Recent Filing)$702.57M
Total Debt (Recent Filing)$78.95M
Price to Earnings (P/E)-6.5
Nov 02, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.80
Shares Outstanding55,739,306
10 Day Avg. Volume294,373
30 Day Avg. Volume341,632
Standard Deviation0.13
Financial Highlights & Ratios
Price to Book (P/B)1.43
Price to Sales (P/S)205.53
Price to Cash Flow (P/CF)-5.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue47.73
Enterprise Value/Gross Profit60.30
Enterprise Value/Ebitda-3.01
Price Target Upside56.57% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Agios Pharma’s price range in the past 12 months?
Agios Pharma lowest stock price was $21.07 and its highest was $31.87 in the past 12 months.
    What is Agios Pharma’s market cap?
    Currently, no data Available
    When is Agios Pharma’s upcoming earnings report date?
    Agios Pharma’s upcoming earnings report date is Nov 02, 2023 which is in 32 days.
      How were Agios Pharma’s earnings last quarter?
      Agios Pharma released its earnings results on Aug 03, 2023. The company reported -$1.51 earnings per share for the quarter, beating the consensus estimate of -$1.561 by $0.051.
        Is Agios Pharma overvalued?
        According to Wall Street analysts Agios Pharma’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Agios Pharma pay dividends?
          Agios Pharma does not currently pay dividends.
          What is Agios Pharma’s EPS estimate?
          Agios Pharma’s EPS estimate is -$1.7.
            How many shares outstanding does Agios Pharma have?
            Agios Pharma has 55,739,307 shares outstanding.
              What happened to Agios Pharma’s price movement after its last earnings report?
              Agios Pharma reported an EPS of -$1.51 in its last earnings report, beating expectations of -$1.561. Following the earnings report the stock price went down -0.154%.
                Which hedge fund is a major shareholder of Agios Pharma?
                Among the largest hedge funds holding Agios Pharma’s share is Farallon Capital Management, L.L.C.. It holds Agios Pharma’s shares valued at 76M.


                  Agios Pharma Stock Smart Score

                  The Agios Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Agios Pharma

                  Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.


                  Top 5 ETFs holding AGIO

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Schwab U.S. Broad Market ETF
                  Fidelity Nasdaq Composite Index ETF
                  Vanguard Russell 3000 ETF
                  V-Shares US Leadership Diversity ETF
                  Up to five ETFs with an Outperform Smart Score that hold AGIO. The ETFs are listed according to market value of AGIO within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Aeglea Biotherapeutics
                  Merck & Company

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis